Doblase

Doblase Dobutamine Hydrochloride 50mg Injection IP is a critical care medication designed to support heart function in patients experiencing severe cardiac conditions. Formulated with Dobutamine Hydrochloride 50mg, this injection belongs to the class of cardiotonic agents and is widely used in hospital settings for managing acute heart failure, cardiogenic shock, and low cardiac output conditions.

Dobutamine works by stimulating beta-1 adrenergic receptors, enhancing myocardial contractility, and improving blood circulation without significantly increasing heart rate. This makes it a preferred choice in emergency and intensive care units where controlled cardiac stimulation is essential.

Packaged in a 5x5ml tray pack ampoule format, Doblase ensures convenience, sterility, and accurate dosing during administration. The injectable solution is typically administered intravenously under strict medical supervision, allowing rapid onset of action and precise titration based on patient response.

Key Benefits:

• Enhances cardiac output efficiently
• Supports patients with heart pump failure
• Fast-acting intravenous formulation
• Reliable composition with proven efficacy

Usage & Safety:

Doblase should only be used under professional healthcare guidance. Continuous monitoring of heart rate, blood pressure, and oxygen levels is essential during therapy to ensure optimal outcomes and minimize risks.

Conclusion:

Doblase Dobutamine Hydrochloride Injection stands as a dependable solution in acute cardiac care, offering targeted support for compromised heart function with precision and safety in clinical environments.